European Journal of Preventive Cardiology and secondary cardiovascular prevention and sport cardiology. It publishes 18 issues yearly and abstracted and indexed in Scopus and the Social Sciences Citation Index. According to the "Journal Citation Reports", its 2016 impact factor is 3.6, ranking it 43th out of 125 journals in the category "Cardiac & Cardiovascular Systems". Areas of interests are Cardiovascular primary and secondary preventions, (including arterial hypertension, dyslipidaemia, diabetes, obesity, smoking cessation, healthy life style promotion), epidemiology, cardiac rehabilitation, exercise training and physiology, sport cardiology, population science intervention. European Journal of Preventive Cardiology The European Journal of Preventive Cardiology is a peer-reviewed medical journal that
Cardiovascular disease with high blood pressure require more than one drug to achieve adequate reduction in blood pressure. Statins are effective in preventing further cardiovascular disease in people with a history of cardiovascular disease. As the event rate is higher in men than in women, the decrease in events is more easily seen in men than women. In those at risk, but without a history of cardiovascular disease (primary prevention), statins decrease the risk of death and combined fatal and non-fatal cardiovascular disease. The benefit, however, is small. A United States guideline recommends statins in those who have a 12% or greater